Clinical Trial Update: Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients

View source ↗

Summary

A completed clinical trial from Fudan University investigates treatment options after progression on fulvestrant in metastatic breast cancer. The study (NCT0354…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Status: COMPLETED